Comprehensive guide to lipidology for endocrinologists and trainees. Covers many therapeutic options including evolving techniques. Discusses management of Dyslipidemia in specific population sectors. Highly illustrated with images, diagrams and tables.

Section 1: Basic Lipidology Human Lipoprotein Metabolism: An OverviewLipoproteins: Mechanisms for AtherogenesisApolipoprotein B Particles and Cardiovascular DiseaseLipoprotein (a): An UpdateMonogenic Lipoprotein Disorders: The Phenotype to Genotype   Section 2: Clinical Lipidology Dietary Fats and Cardiovascular DiseaseDyslipidemia: Relationship to Insulin Resistance, Fatty Liver, and Sub-Clinical AtherosclerosisRisk Assessment of Different Lipid Markers: Clinical Appraisal and Goal of TherapyRethinking Good Cholesterol: Understanding the Role of HDLTriglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease RiskNon-HDL is a Better Marker than LDL for CVD BenefitsApproach to the Patient with Lipid DisordersLaboratory Assessment of Lipoproteins: Principles and PitfallsStatins Diabetogenicity: Are All Same?   Section 3: Therapeutic Lipidology The Effects of Diet and Exercise in HyperlipidemiaNAFLD: The Lipid Disease of the Liver and the Effect of Lipid-lowering DrugsBeyond Statins: Who and When to Prescribe?Role of TG-lowering Drugs on Cardiovascular Outcomes: Focus on OM3FAHDL-targeted Therapies: Progress and FutureStatin Intolerance: Impact on Statin Therapy - Assessment and ManagementDiabetic Dyslipidemia: Current Concept and GuidelinesComparative Analysis of Major Cholesterol Guidelines: Endocrinologists’ PerspectiveInternational Lipid Guidelines: Implications for Indian Patients: A Cardiologist’s ViewpointLipoprotein ApheresisEvolving Targets of Therapies: PCSK9 and Beyond   Section 4: Dyslipidemia in Special Population Lipid Management in Chronic Kidney DiseaseDyslipidemia in Children and Adolescents: Screening, Diagnosis and ManagementDyslipidemia in PregnancyDrug Treatment of Dyslipidemia in Older AdultsDyslipidemia in HIV